AMRX

Amneal Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality5/10
  • Growth↑ 8/10
  • Value↓ 4/10
Amneal Pharmaceuticals sales and earnings growth
AMRX Growth
Good
  • Revenue Y/Y↑ 6.03%
  • EPS Y/Y↑ 1075.00%
  • FCF Y/Y↓ -14.08%
Amneal Pharmaceuticals gross and profit margin trends
AMRX Profitability
Neutral
  • Gross margin ↑ 38.70%
  • EPS margin↓ 4.00%
  • ROIC 5Y↓ 5.39%
Amneal Pharmaceuticals net debt vs free cash flow
AMRX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↑ 11.9
  • Interest coverage↓ 1.5

Amneal Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks